Medpace Q4/FY2022 earnings release; detailed results not available in filing text

Medpace Holdings, Inc.

2022-FY EPS reported $7.28 revenue$1,459,996,000

Medpace issued a press release on February 13, 2023 for Q4 and full year 2022 results.
The full text of the press release is referenced as Exhibit 99.1 but not included in provided text.
Without exhibit content, specific revenue, EPS, or guidance changes cannot be summarized.
Investors should refer to the company's website or subsequent filings for financial details.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Medpace Holdings, Inc. reported financial results for three and twelve months ended December 31, 2022.

Period: three and twelve months ended December 31, 2022
Result: reported results

Exact text from the filing

issued a press release announcing its financial results for the three and twelve months ended December 31, 2022

View on SEC.gov

Browse all earnings releases →

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-23-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.